Jimmy Ruiz, MD, reflects on his career journey in North Carolina and the transformative progress in lung cancer treatment. Early in his career, limited tools like chemotherapy presented…
David Simel, MD, and William Kim, MD, explore renal cell carcinoma in this JAMA Clinical Review podcast. They discuss key insights from the 2019 Nobel Prize research on…
Advances in non-small cell lung cancer (NSCLC) treatment have transformed care from a one-size-fits-all approach in the 1990s to highly personalized regimens today. Treatment now considers actionable mutations…
Faith Davies, MD, shares insights from the IMS 2024 session on high-risk disease, highlighting the debut of a unified high-risk definition. This new framework incorporates 17p deletions, mutations,…
The dialogue between Venugopal, MD, and Nabhan, MD, delves into unresolved challenges in treating chronic myeloid leukemia (CML). Venugopal emphasizes the need for targeted therapies in CML blast…
Lobular breast cancer presents unique challenges in detection and treatment due to its diffuse growth pattern and differences from ductal cancers. Liz O’Riordan, MD, shares her personal journey,…
Colon cancer is the third leading cause of cancer-related deaths in the U.S., but early detection saves lives. This video explains how colon cancer starts as slow-growing polyps…
In this insightful discussion on the Rena Malik MD podcast, Rena Malik, MD interviews Stacy Loeb, MD, a Professor of Urology at New York University. They explore the…
Christopher Patriquin, MD, Hematologist at Toronto General Hospital, discusses the challenges of diagnosing paroxysmal nocturnal hemoglobinuria (PNH) due to its varied symptoms, such as thrombosis, anemia, and unusual…
